Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 654

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 654
---
vardi’s executive compensation programs as they relate to the executive officers named below (named executive officers), including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. For the year ended December 31, 2024, Tvardi’s named executive officers were: • Imran Alibhai, Ph.D., Tvardi Chief Executive Officer and Director; • John Kauh, M.D., Tvardi Chief Medical Officer; and • Dan Conn, J.D., M.B.A., Tvardi Chief Financial Officer. 2024 Summary Compensation Table The following table presents all of the compensation awarded to or earned by or paid to Tvardi’s named executive officers.

| Name and Principal Position          | ​ | ​ | Year |   |      |   | ​ | ​ |  Salary($) |   |         |   | ​ | ​ |   Bonus($) |   |         |   | ​ | ​ | Optionawards($)(1) |   |   |   | ​ | ​ | All othercompensation($)(3) |   |        |   | ​ | ​ | Total($) |   |         |   | ​ |
|:-------------------------------------|:--|:--|-----:|:--|-----:|:--|:--|:--|-----------:|:--|--------:|:--|:--|:--|-----------:|:--|--------:|:--|:--|:--|-------------------:|:--|:--|:--|:--|:--|----------------------------:|:--|-------:|:--|:--|:--|---------:|:--|--------:|:--|:--|
| Imran Alibhai, Ph.D.                 
 Chief Executive Officer and Director | ​ | ​ |    ​ | ​ | 2024 | ​ | ​ | ​ |          ​ | $ | 551,050 | ​ | ​ | ​ |          ​ | $ | 275,525 | ​ | ​ | ​ |                  ​ | ​ | — | ​ | ​ | ​ |                           ​ | $ | 30,755 | ​ | ​ | ​ |        ​ | $ | 857,330 | ​ | ​ |
| ​                                    | ​ | ​ | 2023 | ​ |    ​ | ​ | ​ | $ |    535,000 | ​ |       ​ | ​ | ​ | $